Abstract:Purpose: The number of people with type 2 diabetes (T2D) is growing rapidly worldwide. Islet beta-cell dysfunction and failure are the main causes of T2D pathological processes. The aim of this study was to elucidate the underlying pathways and coexpression networks in T2D islets. Materials and methods: We analyzed the differentially expressed genes (DEGs) in the data set GSE41762, which contained 57 nondiabetic and 20 diabetic samples, and developed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Protein-protein interaction (PPI) network, the modules from the PPI network, and the gene annotation enrichment of modules were analyzed as well. Moreover, a weighted correlation network analysis (WGCNA) was applied to screen critical gene modules and coexpression networks and explore the biological significance. Results: We filtered 957 DEGs in T2D islets. Then GO and KEGG analyses identified that key pathways like inflammatory response, type B pancreatic cell differentiation, and calcium ion-dependent exocytosis were involved in human T2D. Three significant modules were filtered from the PPI network. Ribosome biogenesis, extrinsic apoptotic signaling pathway, and membrane depolarization during action potential were associated with the modules, respectively. Furthermore, coexpression network analysis by WGCNA identified 13 distinct gene modules of T2D islets and revealed four modules, which were strongly correlated with T2D and T2D biomarker hemoglobin A1c (HbA1c). Functional annotation showed that these modules mainly enriched KEGG pathways such as NV-kappa B signaling pathway, tumor necrosis factor signaling pathway, cyclic adenosine monophosphate signaling pathway, and peroxisome proliferators-activated receptor signaling pathway. Conclusion: The results provide potential gene pathways and underlying molecular mechanisms for the prevention, diagnosis, and treatment of T2D.

The role of exosome derived miRNAs in inter-cell crosstalk among insulin-related organs in type 2 diabetes mellitus

Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus

Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus

Emerging roles of exosomal miRNAs in diabetes mellitus

Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus

Exosomes and Obesity-Related Insulin Resistance

[Exosomes and Their Roles in Diabetes Mellitus and Its Complications: from Pathogenic, Diagnostic and Therapeutical Perspectives].

The role of miRNAs carried by extracellular vesicles in type 2 diabetes and its complications

Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications

Targeting the microRNAs in exosome: A potential therapeutic strategy for alleviation of diabetes-related cardiovascular complication

Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus

Exosomes; a Potential Source of Biomarkers, Therapy, and Cure for Type-1 Diabetes

Relationship between Circulating miRNA and Type 2 Diabetes

Inter-organ crosstalk during development and progression of type 2 diabetes mellitus

Role of extracellular vesicles in insulin resistance: Signaling pathways, bioactive substances, miRNAs, and therapeutic potential

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Effect of adipose‐derived exosome and exosomal miRNA on glycolipid metabolism

Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders

MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

Researches on the Mechanism of Exosomes in Diabetes Mellitus

The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment